CD8A and neoplasm: Because Tregs have been regarded as a critical hurdle in CD8+ CTL-mediated anti-tumour immunity, a better understanding of their accumulation would favour strategies designed to regulate the balance between Tregs and effector T cells within EBVaGC, thus promoting the future immunotherapy in EBVaGC.